Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants

Vox Sanguinis

Volumn 79, Issue 3, 2000, Pages 156-160

  Aznar, J A ^a   Bonanad, S ^b   Montoro, J M ^a   Hurtado, C ^b   Cid, A R ^a   Soler, M A ^b   De Miguel, A ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Centro de Transfusion de la Comunidad Valenciana   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; FRESH FROZEN PLASMA; METHYLENE BLUE; PROTHROMBIN; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD CLOTTING FACTOR DEFICIENCY; BLOOD STORAGE; CONTROLLED STUDY; CRYOPRECIPITATE; FIBRINOGEN DEFECT; HUMAN; HUMAN TISSUE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTHROMBIN TIME; SUPERNATANT; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS INACTIVATION; VON WILLEBRAND DISEASE;

EID: 0033673215     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031234     Document Type: Article

References (20)

1. Attenuation of viruses in therapeutic plasma
2. Solvent/detergent-treated plasma: A virus-inactivated substitute for fresh frozen plasma
3. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light
4. Photodynamic virus inactivation of blood components
5. Rapid inactivation of HIV-1 in single donor preparations of human fresh frozen plasma by methylene blue/light treatment
6. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma
7. Indicaciones tera-peuticas del plasma fresco fotoinactivado con azul de metileno
8. Factor VIII/von Willebrand factor molecular complex in methylene blue-treated fresh plasma
9. Indicaciones clinicas y riesgos del plasma fresco congelado. Subdireccion General de Planifi-cation Sanitaria. Ministerio de Sanidad y Con-sumo (Conferencia de Consenso)
10. No evidence for neoan-tigens in human plasma after photochemical virus inactivation
11. An electrophoretic study and amino acid analysis of blood proteins before and after photodynamic treatment of human plasma
12. No evidence for protein modifications in fresh frozen plasma after photochemical treatment: An analysis by high-resolution two-dimensional electrophoresis
13. Luminography - An alternative assay for detection of von Willebrand factor multimers
14. Methylene blue virus inactivated fresh frozen plasma (MB-VIP) in the treatment of patients with thrombotic thrombocytopenic purpura (TTP)
15. The management of factor XI deficiency
16. Antibodies to von Wille-brand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
17. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome
18. A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation